WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005038030) RECOMBINANT VACCINES AND USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/038030    International Application No.:    PCT/EP2004/011512
Publication Date: 28.04.2005 International Filing Date: 13.10.2004
IPC:
C07K 14/47 (2006.01), C07K 14/74 (2006.01)
Applicants: JOHANNES GUTENBERG-UNIVERSITÄT MAINZ, VERTRETEN DURCH DEN PRÄSIDENTEN [DE/DE]; Postfach, 55099 Mainz (DE) (For All Designated States Except US).
TÜRECI, Özlem [DE/DE]; (DE) (For US Only).
SAHIN, Ugur [TR/DE]; (DE) (For US Only).
KREITER, Sebastian [DE/DE]; (DE) (For US Only)
Inventors: TÜRECI, Özlem; (DE).
SAHIN, Ugur; (DE).
KREITER, Sebastian; (DE)
Agent: VOSSIUS, Volker; Geibelstrasse 6, 81679 München (DE)
Priority Data:
103 47 710.1 14.10.2003 DE
Title (DE) REKOMBINATE IMPFSTOFFE UND DEREN VERWENDUNG
(EN) RECOMBINANT VACCINES AND USE THEREOF
(FR) VACCINS RECOMBINES ET LEUR UTILISATION
Abstract: front page image
(DE)Die vorliegende Erfindung betrifft Fusionsmoleküle von Antigenen, die dafür kodierenden Nukleinsäuren und die Verwendung derartiger Fusionsmoleküle und Nukleinsäuren. Insbesondere betrifft die Erfindung Fusionsmoleküle, die ein Antigen und die Transmembranregion und cytoplasmatische Region eines MHC-Moleküls bzw. die cytoplasmatische Region eines MHC oder eines SNARE-Moleküls umfassen.
(EN)The present invention relates to fusion molecules of antigens, the nucleic acids coding therefor and the use of such fusion molecules and nucleic acids. In particular, said invention relates to fusion molecules, comprising an antigen and the transmembrane region and cytoplasmic region of a MHC molecule and/or the cytoplasmic region of a MHC or a SNARE molecule.
(FR)La présente invention concerne des molécules de fusion d'antigènes, les acides nucléiques qui codent pour celles-ci, et l'utilisation de molécules de fusion et d'acides nucléiques de ce type. L'invention concerne en particulier des molécules de fusion qui comprennent un antigène ainsi que la zone transmembranaire et la zone cytoplasmique d'une molécule CMH ou la zone cytoplasmique d'une molécule de CMH ou d'une molécule SNARE.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)